The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.

Application process for the ALBUS Awards 2024 closed. The awardees will be announced in July 2024.

Applications for the next edition 2024 will be accepted between 01/11/2024 and 30/04/2025.

To see the 2023 ALBUS Award winners please click here.